LAKE FOREST, Ill. (AP) _ Assertio Therapeutics, Inc. (ASRT) on Monday reported a loss of $192.6 million in its fourth quarter.
The Lake Forest, Illinois-based company said it had a loss of $2.65 per share. Losses, adjusted for non-recurring costs and stock option expense, were 14 cents per share.
The drugmaker posted revenue of $59.2 million in the period.
For the year, the company reported a loss of $217.2 million, or $3.07 per share, swinging to a loss in the period. Revenue was reported as $229.5 million.
In the final minutes of trading on Monday, the company's shares hit $1.07. A year ago, they were trading at $4.08.